製薬用膜ろ過技術市場- 世界の産業規模、シェア、動向、機会、予測、材料別、技術別、用途別、地域別、競合別、2020-2030年

世界の製薬用膜ろ過技術市場は2024年に58億9,000万米ドルとなり、2030年まで9.12%のCAGRで成長すると予測されています。

膜ろ過は、医薬品の分離、精製、滅菌を容易にすることで、医薬品製造において極めて重要な役割を果たしています。このプロセスでは、多孔質膜を使用して特定の成分を選択的に通過させる一方、汚染物質を保持することで、製品の品質と安全性を確保しています。特に、注射剤や点眼剤などの無菌医薬品製造には不可欠です。市場拡大の原動力となっているのは、人口の高齢化、慢性疾患の罹患率の増加、世界のヘルスケアへのアクセス強化などを背景とした医薬品生産量の増加です。ワクチン、モノクローナル抗体、バイオシミラーなどのバイオ医薬品に対する需要の高まりは、高度な膜ろ過の必要性をさらに高めています。FDAやEMAのような規制機関からの圧力も、厳格な汚染管理を必要とし、ろ過技術の役割を強化しています。アルファ・ラバルが2022年に多目的膜システムを発売するなど、新興市場や継続的な技術革新が採用を加速しており、膜ろ過は最新の医薬品製造に不可欠な要素となっています。

市場促進要因

医薬品生産の増加

主な市場課題

スケールアップの課題

主な市場動向

アウトソーシングの増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の製薬用膜ろ過技術市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 材質別（ポリエーテルサルフォン（PES）、混合セルロースエステル＆セルロースアセテート（MCE＆CA）、ポリフッ化ビニリデン（PVDF）、ナイロンメンブレンフィルターなど）
  • 技術別（精密濾過、限外濾過、ナノ濾過、その他）
  • 用途別（最終製品処理、原料ろ過、細胞分離、水浄化、空気浄化）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 アジア太平洋地域の製薬用膜ろ過技術市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州の製薬用膜ろ過技術市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米の製薬用膜ろ過技術市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米の製薬用膜ろ過技術市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの製薬用膜ろ過技術市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の製薬用膜ろ過技術市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 PESTEL分析

第16章 競合情勢

• 3M Company
• Danaher Corporation
• GE Healthcare
• GEA Group
• Graver Technologies
• Merck Millipore
• Parker Hannifin Corporation
• Repligen Corporation
• Sartorius Stedim Biotech GmbH
• Thermo Fisher Scientific Inc.

第17章 戦略的提言

第18章 調査会社について・免責事項

The Global Pharmaceutical Membrane Filtration Technologies Market was valued at USD 5.89 billion in 2024 and is expected to grow at a CAGR of 9.12% through 2030. Membrane filtration plays a pivotal role in pharmaceutical manufacturing by facilitating the separation, purification, and sterilization of pharmaceutical products. This process uses porous membranes to selectively allow specific components to pass while retaining contaminants, thus ensuring product quality and safety. It is especially critical for sterile drug production, including injectables and ophthalmic solutions. The market's expansion is fueled by rising pharmaceutical output, driven by an aging population, increased chronic disease incidence, and enhanced global healthcare access. The growing demand for biopharmaceuticals such as vaccines, monoclonal antibodies, and biosimilars further propels the need for advanced membrane filtration. Regulatory pressures from agencies like the FDA and EMA also necessitate stringent contamination control, reinforcing the role of filtration technologies. Emerging markets and continuous innovations-such as Alfa Laval's 2022 launch of a multipurpose membrane system-are accelerating adoption, making membrane filtration an integral component of modern pharmaceutical production.

Key Market Drivers

Rising Pharmaceutical Production

The consistent growth of the global pharmaceutical sector, fueled by rising population, aging demographics, and chronic illness prevalence, is a major driver for membrane filtration technologies. To meet rising demand, pharmaceutical firms are expanding production across drug categories-ranging from small molecules to complex biopharmaceuticals and vaccines. For instance, Meissner Corporation's USD 250 million investment in 2023 to build a U.S.-based facility highlights the focus on boosting microfiltration capabilities and ensuring supply chain resilience. Each drug type requires specific filtration processes for sterilization and purification, reinforcing the indispensable role of membrane technologies. Moreover, as biopharmaceutical production increases, so does the demand for high-performance filtration systems that ensure purity and safety. Maintaining product integrity and adhering to stringent regulatory standards make membrane filtration essential in safeguarding pharmaceutical quality during large-scale manufacturing.

Key Market Challenges

Scale-Up Challenges

Scaling membrane filtration systems from laboratory settings to full-scale production presents several technical and operational hurdles. Key variables such as membrane fouling, pressure dynamics, and mass transfer may behave unpredictably at larger scales, affecting filtration consistency. Fouling becomes more pronounced during scale-up, necessitating advanced mitigation strategies to maintain efficiency. Larger systems also introduce complex flow dynamics that require precise calibration to avoid membrane damage or suboptimal filtration. Regulatory validation of large-scale operations demands rigorous testing to prove reliability and adherence to quality standards. Moreover, membrane materials must withstand high operational stress over extended use. The scale-up process also raises cost concerns, involving higher capital expenditure, operating costs, and resource usage. Striking a balance between economic viability and process reliability remains a significant challenge for pharmaceutical manufacturers adopting large-scale membrane filtration.

Key Market Trends

Increased Outsourcing

The trend of outsourcing filtration processes to contract manufacturing organizations (CMOs) is gaining momentum in the pharmaceutical industry. CMOs offer expertise in membrane filtration technologies, enabling pharmaceutical firms to focus on core functions like drug development and marketing. These organizations provide scalable and cost-efficient solutions, often reducing capital investment burdens for pharma companies. By leveraging economies of scale and specialized infrastructure, CMOs offer flexibility in production and quicker adaptation to market demands. Moreover, their deep regulatory knowledge ensures compliance with GMP standards, easing the regulatory approval pathway. Outsourcing also minimizes operational risks, as CMOs often maintain backup systems to prevent disruptions. This growing reliance on third-party providers reflects a strategic shift toward efficiency, compliance, and scalability in pharmaceutical manufacturing.

Key Market Players

• 3M Company
• Danaher Corporation
• GE Healthcare
• GEA Group
• Graver Technologies
• Merck Millipore
• Parker Hannifin Corporation
• Repligen Corporation
• Sartorius Stedim Biotech GmbH
• Thermo Fisher Scientific Inc

Report Scope:

In this report, the Global Pharmaceutical Membrane Filtration Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Membrane Filtration Technologies Market, By Material:

• Polyethersulfone (PES)
• Mixed Cellulose Ester & Cellulose Acetate (MCE & CA)
• Polyvinylidene Difluoride (PVDF)
• Nylon Membrane Filters
• Others

Pharmaceutical Membrane Filtration Technologies Market, By Technique:

• Microfiltration
• Ultrafiltration
• Nanofiltration
• Others

Pharmaceutical Membrane Filtration Technologies Market, By Application:

• Final Product Processing
• Raw Material Filtration
• Cell Separation
• Water Purification
• Air Purification

Pharmaceutical Membrane Filtration Technologies Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Membrane Filtration Technologies Market.

Available Customizations:

Global Pharmaceutical Membrane Filtration Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Membrane Filtration Technologies Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Material (Polyethersulfone (PES), Mixed Cellulose Ester & Cellulose Acetate (MCE & CA), Polyvinylidene Difluoride (PVDF), Nylon Membrane Filters, others)
  • 5.2.2. By Technique (Microfiltration, Ultrafiltration, Nanofiltration, others)
  • 5.2.3. By Application (Final Product Processing, Raw Material Filtration, Cell Separation, Water Purification, Air Purification)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Pharmaceutical Membrane Filtration Technologies Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Material
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Material
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
  • 6.3.2. India Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Material
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
  • 6.3.3. Australia Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Material
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application
  • 6.3.4. Japan Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Material
      • 6.3.4.2.2. By Technique
      • 6.3.4.2.3. By Application
  • 6.3.5. South Korea Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Material
      • 6.3.5.2.2. By Technique
      • 6.3.5.2.3. By Application

7. Europe Pharmaceutical Membrane Filtration Technologies Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Material
  • 7.2.2. By Technique
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Material
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Material
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
  • 7.3.3. Spain Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Material
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Material
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Application
  • 7.3.5. United Kingdom Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Material
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Application

8. North America Pharmaceutical Membrane Filtration Technologies Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Material
  • 8.2.2. By Technique
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Material
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
  • 8.3.2. Mexico Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Material
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
  • 8.3.3. Canada Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Material
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application

9. South America Pharmaceutical Membrane Filtration Technologies Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Material
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Material
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Material
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Material
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application

10. Middle East and Africa Pharmaceutical Membrane Filtration Technologies Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Material
  • 10.2.2. By Technique
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Material
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Material
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Material
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Pharmaceutical Membrane Filtration Technologies Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. 3M Company
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. Danaher Corporation
• 16.3. GE Healthcare
• 16.4. GEA Group
• 16.5. Graver Technologies
• 16.6. Merck Millipore
• 16.7. Parker Hannifin Corporation
• 16.8. Repligen Corporation
• 16.9. Sartorius Stedim Biotech GmbH
• 16.10.Thermo Fisher Scientific Inc.

17. Strategic Recommendations

18. About Us & Disclaimer